ÀÇ·á¿ë Àΰø Àç·á ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Medical Engineered Materials Market, By Product Type, By Application, By End User, By Geography
»óǰÄÚµå
:
1424302
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2023³â 12¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ ÀÇ·á¿ë Àΰø Àç·á ½ÃÀåÀº 2023³â 196¾ï 6,000¸¸ ´Þ·¯¿¡¼ 2030³â¿¡´Â 501¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 14.3%ÀÔ´Ï´Ù.
¸®Æ÷Æ® ¹üÀ§ |
¸®Æ÷Æ® »ó¼¼ |
±âÁسâ |
2022³â |
2023/2024³â ½ÃÀå ±Ô¸ð |
196¾ï 6,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2018-2021³â |
¿¹Ãø ±â°£ |
2023-2030³â |
¿¹Ãø ±â°£ 2023³â/2024-2030³â/2031³â CAGR |
14.30% |
2030/2031³â °¡Ä¡ ¿¹Ãø |
501¾ï 1,000¸¸ ´Þ·¯ |
µµÇ¥ 1. ¼¼°èÀÇ ÀÇ·á¿ë Àΰø Àç·á ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â

ÀÇ·á¿ë Àΰø Àç·á´Â ÀÇ·á »ê¾÷¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ ¿ëµµ¿¡ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àç·á´Â ÀÇ·á±â±â, ÀÓÇöõÆ® ¹× ÀåºñÀÇ Æ¯Á¤ ¿ä±¸ »çÇ×À» ÃæÁ·Çϵµ·Ï Ưº°È÷ ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ ¼ÒÀçµéÀº ¶Ù¾î³ °µµ, ³»±¸¼º ¹× »ýü ÀûÇÕ¼ºÀ» Á¦°øÇÏ¿© ¾ÈÀüÇϰí È¿°úÀûÀÎ ÀÇ·á ¼Ö·ç¼ÇÀ» º¸ÀåÇÕ´Ï´Ù. Àç·á °úÇаú °øÇÐÀÇ ´«ºÎ½Å ¹ßÀüÀ¸·Î ÀÇ·á ºÐ¾ß¿¡¼ ¼¼¶ó¹Í, ±Ý¼Ó, Æú¸®¸Ó, º¹ÇÕÀç·á¿Í °°Àº Àç·áÀÇ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. »õ·Î¿î »ýü °øÇÐ Àç·á´Â Àΰ£ Á¶Á÷À» Ãæ½ÇÇÏ°Ô ¸ð¹æÇϰí Á¶Á÷ Àç»ýÀ» µµ¿ï ¼ö ÀÖµµ·Ï °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀÇ ¹è°æ¿¡´Â ÀÇ·á ÀýÂ÷ ¹× Ä¡·áÀÇ º¹À⼺ Áõ°¡¿Í ÇÔ²² ȯÀÚ °á°ú¸¦ °³¼±ÇØ¾ß ÇÒ Çʿ伺ÀÌ ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ÀÇ·á¿ë Àΰø Àç·á »ê¾÷Àº ÀǷḦ ÇÑ ´Ü°è ´õ ¹ßÀü½Ãų ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ Àç·á ¼Ö·ç¼ÇÀ» °³¹ßÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ :
¼¼°è ÀÇ·á¿ë ÀΰøÀç·á ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ, ´ç´¢º´, ¾Ï°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÀÇ·á±â±â ¹× ÀÓÇöõÆ®¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Àç·á´Â »ýü ÀûÇÕ¼º, ³»±¸¼º, À¯¿¬¼º µî ¿ì¼öÇÑ Æ¯¼ºÀ» °¡Áö°í ÀÖÀ¸¸ç, ÷´Ü ÀÇ·á±â±â °³¹ß¿¡ ÇʼöÀûÀÔ´Ï´Ù. Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸´Â ¸¸¼ºÁúȯ¿¡ °É¸®±â ½±°í Àü¹®ÀûÀÎ ÀÇ·á ½Ã¼úÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ÀÇ·á¿ë Àΰø Àç·áÀÇ »ç¿ëÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ ¹ÙÀÌ¿À¼ÒÀç ¹× ³ª³ë ±â¼ú ±â¹Ý ÄÚÆÃÀÇ °³¹ß°ú °°Àº Àç·á °úÇÐÀÇ ±â¼ú ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
±×·¯³ª ½ÃÀåÀº ¸î °¡Áö ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA) µî ±ÔÁ¦ ´ç±¹ÀÇ ¾ö°ÝÇÑ ±ÔÁ¦¿Í ǰÁú ±âÁØÀº ½ÃÀå Âü¿© ±â¾÷¿¡°Ô Àå¾Ö¹°ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦¸¦ ÁؼöÇÏ°í »õ·Î¿î Àç·á¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» ¾ò´Â µ¥´Â ¸¹Àº ½Ã°£°ú ºñ¿ëÀÌ ¼Ò¿äµË´Ï´Ù. ¶ÇÇÑ ÀÇ·á¿ë Àΰø Àç·áÀÇ °³¹ß ¹× Á¦Á¶¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ¼¼°èÀÇ ÀÇ·á¿ë Àΰø Àç·á ½ÃÀåÀ» »ó¼¼ ºÐ¼®Çϰí 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø ±â°£(2023-2030³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
- ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ¼³¸íÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ ¼³¸íÇϰí ÀÖ½À´Ï´Ù.
- ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
- ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±â¹ÝÇÏ¿© ¼¼°èÀÇ ÀÇ·á¿ë Àΰø Àç·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.
- º» ¸®Æ÷Æ®·ÎºÎÅÍ ÀλçÀÌÆ®¿¡ ÀÇÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ ¹× ±â¾÷ÀÇ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° ¹ß¸Å, À¯Çü ¾÷, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ½ÃÇàÇÒ ¼ö ÀÖ½À´Ï´Ù.
- ¼¼°èÀÇ ÀÇ·á¿ë Àΰø Àç·á ½ÃÀå ¸®Æ÷Æ®´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü¿©¾÷ü, À繫 ¾Ö³Î¸®½ºÆ® µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.
- ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ÀÇ·á¿ë Àΰø Àç·á ½ÃÀåÀÇ ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
- ¸®Æ÷Æ® ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¿µÇ⠺м®
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ±ÔÁ¦ ½Ã³ª¸®¿À
- Á¦Ç°ÀÇ ¹ß¸Å/½ÂÀÎ
- PEST ºÐ¼®
- PorterÀÇ »ê¾÷ ºÐ¼®
- ÇÕº´°ú Àμö ½Ã³ª¸®¿À
Á¦4Àå ¼¼°èÀÇ ÀÇ·á¿ë Àç·á ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ
- ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
- °ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
- °æÁ¦Àû ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ÀÇ·á¿ë Àç·á ½ÃÀå, Á¦Ç° À¯Çüº°, 2018-2030³â
- ¼·Ð
- ±Ý¼Ó »ýü Àç·á
- ¼¼¶ó¹Í »ýü Àç·á
- °íºÐÀÚ »ýü Àç·á
- õ¿¬ »ýü Àç·á
- º¹ÇÕÀç·á »ýü Àç·á
- ±âŸ
Á¦6Àå ¼¼°èÀÇ ÀÇ·á¿ë Àç·á ½ÃÀå, ¿ëµµº°, 2018-2030³â
- ¼·Ð
- ½ÉÀåÇ÷°ü
- Á¤Çü¿Ü°ú
- Ä¡°ú
- ¼ºÇü¿Ü°ú
- â»ó Ä¡À¯
- ½Å°æÇÐÀû
- ±âŸ
Á¦7Àå ¼¼°èÀÇ ÀÇ·á¿ë Àç·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â
- ¼·Ð
- º´¿ø
- Ŭ¸®´Ð
- ¿¬±¸±â°ü
- ±âŸ
Á¦8Àå ¼¼°èÀÇ ÀÇ·á¿ë Àç·á ½ÃÀå, Áö¿ªº°, 2018-2030³â
- ¼·Ð
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ASEAN ±¹°¡
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦9Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Á¦Ç° À¯Çüº° ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü, 2019-2030³â
- ¿ëµµº° ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü, 2019-2030³â
- ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü, 2019-2030³â
- ±¹°¡º° ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü, 2019-2030³â
- GCC ±¹°¡
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«
- Áß¾Ó¾ÆÇÁ¸®Ä«
- ºÏ¾ÆÇÁ¸®Ä«
- ±âŸ Áßµ¿
Á¦10Àå °æÀï ±¸µµ
- Evonik Industries AG
- Covestro AG
- BASF SE
- Solvay
- SABIC
- Trelleborg AB
- DSM
- Celanese Corporation
- DuPont de Nemours Inc.
- Others
Á¦11Àå ¼½¼Ç
KSA
¿µ¹® ¸ñÂ÷
Global medical engineered materials market is expected to reach US$ 50.11 Bn by 2030, from US$ 19.66 Bn in 2023, exhibiting a CAGR of 14.3% during the forecast period.
Report Coverage |
Report Details |
Base Year: |
2022 |
Market Size in 2023/2024: |
US$ 19.66 Bn |
Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023/2024 to 2030/2031 CAGR: |
14.30% |
2030/2031 Value Projection: |
US$ 50.11 Bn |
Figure 1. Global Medical Engineered Materials Market Share (%), By Region, 2023

Medical engineered materials play a crucial role in the healthcare industry, and provides innovative solutions for a wide range of applications. These materials are specifically designed to meet the unique requirements of medical devices, implants, and equipment. These offer exceptional strength, durability, and biocompatibility, ensuring safe and effective healthcare solutions. There has been significant advancement in materials science and engineering which has expanded the use of materials like ceramics, metals, polymers, and composites in healthcare. Newer bioengineered materials are being developed that can closely mimic human tissues and aid in tissue regeneration. The advances are driven by the need for improved patient outcomes along with increasing complexity of medical procedures and treatments. Overall, the medical engineered materials industry plays a crucial role in developing innovative materials solutions that can elevate healthcare to the next level.
Market Dynamics:
Global medical engineered materials market growth is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and cancer is expected to boost demand for medical devices and implants. These materials offer exceptional properties including biocompatibility, durability, and flexibility, which are crucial in the development of advanced medical devices. Rising geriatric population worldwide is contributing to the market growth. The elderly population is more susceptible to chronic diseases and requires specialized medical treatments, which necessitate the use of medical engineered materials. Moreover, technological advancements in material science, such as the development of bio-based materials and nanotechnology-based coatings, are further driving market growth.
However, the market faces few challenges. Stringent regulations and quality standards imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), can pose hurdles for market players. Compliance with these regulations and obtaining regulatory approvals for new materials can be time-consuming and costly. Furthermore, the high cost associated with the development and manufacturing of medical engineered materials can act as a restraint for market growth.
Key features of the study:
- This report provides in-depth analysis of the global medical engineered materials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global medical engineered materials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Evonik Industries AG, Covestro AG, BASF SE, Solvay, SABIC, Trelleborg AB, DSM, Celanese Corporation, DuPont de Nemours Inc.,
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global medical engineered materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical engineered materials market
Medical Engineered Materials Market Detailed Segmentation:
- By Product Type
- Metallic Biomaterials
- Ceramics Biomaterials
- Polymeric Biomaterials
- Natural Biomaterials
- Composites Biomaterials
- Others
- By Application
- Cardiovascular
- Orthopedic
- Dental
- Plastic Surgery
- Wound Healing
- Neuro-logical
- Others
- By End User
- Hospitals
- Clinics
- Research Institutions
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Top companies in Global Medical Engineered Materials Market:
- Evonik Industries AG
- Covestro AG
- BASF SE
- Solvay
- SABIC
- Trelleborg AB
- DSM
- Celanese Corporation
- DuPont de Nemours Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Medical Engineered Materials Market, By Product Type
- Medical Engineered Materials Market, By Application
- Medical Engineered Materials Market, By End User
- Medical Engineered Materials Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing prevalence of chronic diseases
- Stringent clinical & regulatory requirements
- Applications in personalized medicine
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Medical Engineered Materials Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Medical Engineered Materials Market, By Product Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Metallic Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Ceramics Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Polymeric Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Natural Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Composites Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)
6. Global Medical Engineered Materials Market, By Application, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Plastic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Wound Healing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Neuro-logical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
7. Global Medical Engineered Materials Market , By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
8. Global Medical Engineered Materials Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
- Argentina
- Brazil
- Mexico
- Rest of Latin America
9. Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
- GCC Countries
- Israel
- South Africa
- Central Africa
- North Africa
- Rest of Middle East
10. Competitive Landscape
- Evonik Industries AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Covestro AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BASF SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Solvay
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SABIC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Trelleborg AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DSM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Celanese Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DuPont de Nemours Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Others
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
°ü·ÃÀÚ·á